Prostaglandin E2 regulates vitamin D receptor expression, vitamin D- 24-hydroxylase activity and cell proliferation in an adherent human myeloid leukemia cell line (Ad-HL60)

Prostaglandins and Other Lipid Mediators

Volumn 57, Issue 2-3, 1999, Pages 73-85

  Smith, Susan J ^a   Green, Linda M ^b   Hayes, Michael E ^c   Mawer, E Barbara ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Ad HL60; PGE2; Vitamin D Receptor; Vitamin D 24 hydroxylase

Indexed keywords

CYCLIC AMP; FORSKOLIN; HYDROLASE; LEUKOCYTE ANTIGEN; PROSTAGLANDIN E2; VITAMIN D; VITAMIN D RECEPTOR; 24,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL; CALCITRIOL RECEPTOR; CYTOCHROME P450; PHORBOL 13 ACETATE 12 MYRISTATE; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; CELL DIVISION; CELL STRAIN HL 60; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; PHENOTYPE;

24,25-DIHYDROXYVITAMIN D 3; ANTIGENS, CD; CALCITRIOL; CELL DIVISION; CYCLIC AMP; CYTOCHROME P-450 ENZYME SYSTEM; DINOPROSTONE; FLOW CYTOMETRY; FORSKOLIN; HL-60 CELLS; HUMANS; PHENOTYPE; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; TETRADECANOYLPHORBOL ACETATE;

EID: 0032588303     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00073-2     Document Type: Article

References (36)

1. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 102:(3):1981;937-943.
2. 3 . Arch Biochem Biophys. 251:(1):1986;222-231.
3. Hayes ME, Mawer EB. 1α-Hydroxylated vitamin D metabolites promote differentiation and 24,25-dihydroxyvitamin D synthesis in human leukemia (HL60) cells. In: Norman AW, Schaefer K, Grigoleit H-G, Herrath DV, editors. Vitamin D - Molecular, Cellular and Clinical Endocrinology. Proceedings of the Seventh Workshop on Vitamin D. Berlin: Walter de Gruyter, 1988:344-5.
4. Honda A., Raz A., Needleman P. Induction of cyclo-oxygenase synthesis in human promyelocytic leukemia (HL60) cells during monocytic or granulocytic differentiation. J Biochem. 272:(1):1990;259-262.
5. Chaplinski T.J., Niedel J.E. Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells. J Clin Invest. 70:(5):1982;953-964.
6. Olsson I.L., Breitman T.R., Gallo R.C. Priming of human myeloid leukemic cell lines HL-60 and U937 with retinoic acid for differentiation effects of cyclic adenosine 3′:5′-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Cancer Res. 42:(10):1982;3928-3933.
7. Collins S.J. Review article The HL60 promyelocytic leukemia cell line - Proliferation, differentiation, and cellular oncogene expression . Blood. 70:(5):1987;1233-1244.
8. Harris P., Ralph P. Human leukemic models of myelomoncytic development A review of the HL60 and U937 lines . J Leukoc Biol. 37:(4):1985;407-422.
9. 3. J Mol Endocrinol. 7:(3):1991;185-195.
10. Li C.Y., Lam K.W., Yam C.T. Esterases in human leukocytes. J Histochem Cytochem. 21:1973;1-12.
11. Freemont A.J., Davies J.S. Acid esterase activity in lymphocytes and other cells A comparison of six α-naphthyl based substrates . Med Lab Sci. 39:(4):1982;405-407.
12. Chamness G.C., McGuire W.L. Scatchard plots Common errors in correction and interpretation . Steroids. 26:1975;538-542.
13. 3 synthesis in macrophages from inflammatory arthritic joints. Int J Immunotherapy. 10:(1):1994;1-9.
14. 3 by normal human macrophages. Biochem Biophys Res Com. 127:(2):1985;596-603.
15. Mazzone A., Ricevuti G. Leukocyte CD11/CD18 integrins Biological and clinical relevance . Haematologica. 80:(2):1995;161-175.
16. Arnaout M.A., Dana N., Gupta S., Tenen D.G., Fathallah D.M. Point mutations impairing cell surface expression of the common beta subunit (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency. J Clin Invest. 85:(3):1990;977-981.
17. Nelson C., Rabb H., Arnaout M.A. Genetic cause of leukocyte adhesion molecule deficiency Abnormal splicing and a missense mutation in a conserved region of CD18 impair cell surface expression of beta-2 integrins . J Biol Chem. 267:(5):1992;3351-3357.
18. 450 messenger ribonucleic acid levels in primary cultures of rat renal cells. Endocrinology. 132:(4):1993;1782-1788.
19. 3-differentiated HL60 cells. J Mol Endocrinol. 3:(3):1989;199-205.
20. Hewison M., Barker S., Brennan A., Nathan J., Katz D.R., O'Riordan J.L.H. Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells. Immunology. 68:(2):1989;247-252.
21. Berry J.L., Farquharson C., Whitehead C.C., Mawer E.B. 24,25-Dihydroxyvitamin D production by normal and dyschondroplastic chondrocytes. Bone. 15:(4):1994;461-462.
22. Heys-Jackson SE, Mawer EB. Transfection of VDR in a human small cell lung cancer (SCLC) cell line, NCI-H82, modulates vitamin D hydroxylase activity and reduces cell proliferation. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D - Chemistry, Biology and Clinical Applications of the Steroid Hormone. Proceedings of the Tenth Workshop on Vitamin D; University of California, Riverside, CA, USA, Printing and Reprographics 1997. pp. 230-1.
23. Chen K.S., DeLuca H.F. Cloning of the human 1α,25-dihydroxyvitamin D-3 24-hydroxylase gene promotor and identification of two vitamin D responsive elements. Biochim Biophys Acta. 1263:(1):1995;1-9.
24. 3 upregulates expression of the osteoclast integrin αvβ3. J Biol Chem. 268:(2):1993;1456-1461.
25. 3. J Biol Chem. 268:(36):1993;27371-27380.
26. Duong L.T., Tanaka H., Wesolowski G., Rodan G.A. Role of αMβ2 integrin in osteoclast differentiation. J Bone Miner Res. 8:(S1):1993;S378.
27. Hewison M., Dabrowski M., Faulkner L., et al. Transfection of vitamin D receptor cDNA into the monoblastoid cell line U937. J Immunol. 153:(12):1994;5709-5719.
28. 3 synthesis by synovial fluid macrophages from arthritic joints. Ann Rheum Dis. 51:(5):1992;632-637.
29. 2, frusemide and acetylsalicylate . Clin Sci. 61:(1):1981;53-59.
30. Hewison M., Brennan A., Singh-Ranger R., Walters J.C., Katz D.R., O'Riordan J.L.H. The comparative role of 1,25 dihydroxycholecalciferol and phorbol esters in the differentiation of the U937 cell line. Immunology. 77:(2):1992;304-311.
31. 2 receptors expressed on human monocytic leukaemic cell line, U937. Biochim Biophys Acta. 1177:(1):1993;43-48.
32. 2 receptor activation. FASEB J 1992;6(5)(part 2):A1849.
33. Negishi M., Sugimoto Y., Ichakawa A. Prostanoid receptors and their biological actions. Prog Lipid Res. 32:(4):1993;417-434.
34. 3 on lymphocytes. FEBS Lett. 205:(1):1986;113-116.
35. 2 induction of monoblastic differentiation utilizes both cAMP and non-cAMP dependent signalling systems. Biochim Biophys Acta. 1091:(1):1991;87-95.
36. 3 prolong survival-time of mice inoculated with myeloid-leukemia cells. Proc Natl Acad Sci USA. 80:(1):1983;201-204.